Key Takeaways
- •A consent form supports a clinical discussion; it does not establish that discussion or satisfy every state rule by itself.
- •FDA status must be verified for the actual device function and intended use. Clearance, De Novo authorization and approval are different pathways.
- •A patient signature is not a HIPAA authorization, recording permission or blanket model-training consent.
- •Assess the patient and provider locations, actual service and timing independently. Headquarters alone does not determine applicable law.
- •The wizard has no preselected legal approvals. Unresolved authority, privacy, scope or patient choices keep the record in draft without signature fields.
- •A refusal does not elect another treatment. Requested conditions need provider acceptance and an operational plan before signature-ready output.
- •Patient consent does not satisfy separate clinical decision support governance. California SB503 requires an independent scope and provider/developer review for January 2027.
The legal sources for these instructions are linked below.
What Is AI Healthcare Tool Informed Consent Form?
An AI healthcare disclosure and patient decision record identifies a specific AI use in a specific care encounter. It documents the explanation, the relevant benefits and risks, available alternatives and the decision made by the patient or a person with verified authority.
The actual clinical process matters. The form cannot manufacture informed consent, establish capacity, confirm a device authorization or prove that a required notice was delivered.
This version separates clinical choice from privacy and recording permissions. It preserves liability rights and does not assume that every AI output is reviewed by a clinician.
Preview clinical AI encounter records
- Working draft before location and service review · PDF · Word
- Texas first-service disclosure · PDF · Word
- Texas emergency disclosure · PDF · Word
- Two Texas government and health-service duties · PDF · Word
- Future Rhode Island scribe review · PDF · Word
- Rhode Island licensed provider · PDF · Word
- Covered Rhode Island facility · PDF · Word
- Texas and Rhode Island care · PDF · Word
- Patient declines with provider steps outstanding · PDF · Word
- Service without visit documentation · PDF · Word
- Encounter outside both states · PDF · Word
- Patient sets conditions · PDF · Word
Why This Matters Now
Healthcare AI includes diagnostic support, autonomous results, patient communications, visit documentation and allocation decisions. Those uses have different clinical, device and privacy implications.
Several state requirements depend on the delivery channel and timing. Louisiana requires a spoken disclosure before recording for AI transcription; a written form alone cannot do that. Rhode Island requires notice of AI visit documentation and an accuracy review after the visit.
Current review must distinguish operative rules from future ones. California AB1979 and Colorado SB26-189 require preparation for January 2027; an older bill summary is not enough.
The Legal Backbone
Rhode Island visit documentation
A licensed provider or covered facility using AI to document an in-person or telehealth visit must tell the patient that AI is used for that purpose and review the generated documentation for accuracy after the visit. A patient signature cannot complete the provider’s review. The June 22, 2026 public law designates the chapter as 23-108. A practitioner may still be covered even if the office falls outside the facility definition.
Texas first-service notice
The provider of a covered AI-related health service or treatment must disclose the AI interaction to the recipient or personal representative no later than the first service date. In an emergency the provider gives the notice as soon as reasonably possible. The disclosure must be clear and conspicuous, use plain language and avoid dark patterns. It may be delivered through a hyperlink. A covered governmental consumer interaction has its own timing rule. An AI notice and a patient decision about a specific use are separate records.
Clinical consent and representative authority
Standards and covered procedures vary. New York §2805-d uses a reasonable-practitioner disclosure standard with specific scope, causation and defenses. A representative’s relationship to the patient does not alone establish authority; verify applicable law, scope and restrictions.
HIPAA and purpose-specific permissions
HIPAA has several conditional bases for permitted uses without authorization, not only treatment, payment and operations. Research waivers and limited-data-set arrangements can be relevant. Determine the actual purpose and legal basis; do not label all model training permissible or all non-TPO use authorization-only. A BAA is not a substitute for a lawful purpose.
FDA status and clinical practice
Verify the exact tool, function, version, intended use and applicable pathway. De Novo classification may be Class I or II. Investigational use may require separate processes. Regulatory authorization does not establish patient consent or guarantee an outcome.
Selected state disclosure and practice rules
California §1339.75 governs covered generative clinical communications with channel-specific placement and a read-and-reviewed exception. Utah Chapter 77 distinguishes high-risk regulated interactions and on-request consumer disclosures. Texas HB149 includes healthcare-specific delivery timing. Louisiana and Rhode Island have distinct visit-recording/documentation requirements.
January 2027 preparation
California AB1979 adds clinical-decision-support and licensed-function restrictions and expands specified chatbot privacy coverage. Colorado SB26-189 replaces its earlier framework. Review definitions, exceptions and actual operative dates before deployment; a generic consent form does not implement those obligations.
California SB503 clinical decision support governance
Effective January 1, 2027, §22758 addresses defined clinical decision support and covered developer/deployer roles. It requires reasonable efforts to identify biased-impact risks, developer mitigation and information, and regular deployer monitoring with proportionate mitigation. Independent administrative activities have a limited exclusion; an internal-use documentation exception does not remove all duties. Patient consent cannot replace these controls.
Record actual care and data practices
Identify the encounter, all relevant locations and the person with authority to decide. Record any interpreter or accessibility support actually provided.
Describe the tool’s function and what the human team actually reviews, when it reviews it and how issues are escalated. Do not promise independent interpretation of an autonomous result.
Explain patient-specific benefits, material risks and real alternatives, including access limits and consequences of declining.
Map the information, recipients, purposes, agreements and separate permissions. Confirm any recording disclosure at the required time and through the required channel.
Document questions, the actual decision, follow-up and review evidence. Draft output has no signature fields; signature-ready output still requires the real discussion and execution process.
When You Need This
When explaining a specified AI-supported healthcare service to a patient.
When documenting refusal or an agreed conditional choice without treating either as blanket consent.
When updating an existing clinical disclosure after a material tool, purpose, data-flow or risk change.
How to Fill Out AI Healthcare Tool Informed Consent Form
1. Identify the encounter
Record the patient, provider, actual locations, service and decision date.
2. Verify authority
Check patient capacity or the representative’s decision-specific authority and any restrictions.
3. Explain the tool
Verify regulatory status and describe actual human oversight, benefits, material risks and alternatives.
4. Review information uses
Document each purpose, recipient and legal basis, including required agreements and separate permissions.
5. Complete legal and delivery checks
Review each applicable regime and preserve actual disclosure and implementation evidence.
6. Record the decision
Resolve questions and conditional requests, then document agreement or refusal and the follow-up process.
Key Terms Defined
- Clinical decision
- The patient’s or authorized representative’s choice about the described care use.
- Privacy authorization
- A separate permission with the required legal elements where the relevant data use requires it.
- Regulatory pathway
- The verified device authorization, exemption, investigational status or non-device basis for a particular use.
- Delivery evidence
- A record of when, how and to whom a required disclosure was actually given.
- Conditional agreement
- A decision limited by specified conditions that the provider has accepted and can implement.
Related Documents
Clinical consent versus data authorization
A decision to receive care does not approve unrelated data processing. Assess and obtain separate permissions where required.
Written form versus spoken or embedded notice
A chart form does not replace a pre-recording verbal disclosure or an AI disclaimer within a patient communication.
Refusal versus choosing another treatment
Record the actual refusal and next steps without assuming the patient selected another service.
Draft versus signature-ready record
Drafts preserve unresolved facts and omit signatures. Readiness means documented review has been completed, not a guarantee of legal compliance.
Legal Authorities & Sources
This page is grounded in primary law. The statutes and official resources below are the authorities behind the guidance above. Verify the current text of any statute before relying on it.
- HHS HIPAA Privacy Rule summary
- HHS research permissions
- HHS personal representatives
- HHS cloud computing guidance
- FDA De Novo classification
- FDA regulatory controls
- California CDPH AB3030 guidance
- California AB1979 chaptered text
- California 2026 signed AI legislation
- California statutory effective dates
- Utah Title 13 Chapter 77
- Colorado SB26-189
- New York Public Health Law 2805-d
- Texas HB149 enacted text
- Rhode Island Public Law 199, Chapter 23-108
- Rhode Island enactment confirmation
- Louisiana Act649 enacted text
- Louisiana Act649 effective date
- California SB503, Chapter 857 (2026), final enacted text
Frequently Asked Questions
Create your AI Healthcare Tool Informed Consent Form in minutes.
Describe the proposed tool, affected people and records of any completed steps.